New study examines the oral pathogen Porphyromonas gingivalis ( Pg ) and suggests its influence may extend beyond dental ...

Mito-TEMPO（AbMole，M10919）的作用机制不仅限于简单的ROS清除，它还能调节多种线粒体相关信号通路和细胞生命活动。例如Mito-TEMPO在MCF-7细胞中，逆转了DHA诱导的ROS依赖性自噬激活，通过调节p-AMPKα/p-Ra ...

Pharmacokinetics/Pharmacodynamics: Drug exposure at 200 mg appears to be in the efficacious range, however further results are awaited. Pharmacodynamic data demonstrated rapid and sustained IL-2 ...

Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its ...

Tiziana Life Sciences considers the antibody, known as TZLS-501, to have potential to operate as a standalone business and intends to proceed with steps for a publicly-listed immunology-focused ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

The resolution has been widely misinterpreted as conferring implicit recognition of Palestinian statehood. In fact, it ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are ...

Evaluation in 18 patients with polycythemia vera showed hematocrit control below 45%, accompanied by a "dramatic decrease in ...